{"title":"Recent Developments and Future Prospects of Natural Antimicrobial Bioactive Metabolites Obtained from Endophytic Bacterial Isolate","authors":"Neelam, M. Lal","doi":"10.2174/1573407219666230609124929","DOIUrl":null,"url":null,"abstract":"\n\nAdathoda beddomei (Adosa), a kind of softwood, evergreen, perennial shrub, has been used as a source of endophyte bacteria. Adhatoda beddomei has a wide variety of chemicals, including anthocyanins, aminophylline, alkaloids, cardiac glycosides, isoprenaline, triterpenoids, resins, flavonoids, tannins, sterol, saponins, etc. The root, stem, and leaf parts of Adathoda beddomei are most often used in indigenous medicine. Moreover, the root bark is also used to cure several conditions, including leprosy, fever, and bleeding.\n\n\n\nSome important bioactive metabolites were obtained from endophytes bacteria and analyzed through various techniques (NMR, MASS, FTIR, HPLC, and UV- spectrophotometer) for their bioactive secondary metabolites.\n\n\n\nIn silico calculation was performed to reveal bioactive metabolites with the potential to be antibacterial, and their primary mode of action may include dissolving bacterial and fungal cell walls.\n\n\n\nThe antimicrobial activity of Adathoda beddomei was demonstrated against different pathogenic and non-pathogenic bacteria. Identification of endophytes was done based on external morphological characteristics with the help of a scanning electron microscope (SEM).\n\n\n\nNatural compounds derived from endophyte bacteria with a very low molecular mass can be used to discover new and important structures for different pharmaceuticals and agrochemicals.\n","PeriodicalId":10772,"journal":{"name":"Current Bioactive Compounds","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioactive Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573407219666230609124929","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Adathoda beddomei (Adosa), a kind of softwood, evergreen, perennial shrub, has been used as a source of endophyte bacteria. Adhatoda beddomei has a wide variety of chemicals, including anthocyanins, aminophylline, alkaloids, cardiac glycosides, isoprenaline, triterpenoids, resins, flavonoids, tannins, sterol, saponins, etc. The root, stem, and leaf parts of Adathoda beddomei are most often used in indigenous medicine. Moreover, the root bark is also used to cure several conditions, including leprosy, fever, and bleeding.
Some important bioactive metabolites were obtained from endophytes bacteria and analyzed through various techniques (NMR, MASS, FTIR, HPLC, and UV- spectrophotometer) for their bioactive secondary metabolites.
In silico calculation was performed to reveal bioactive metabolites with the potential to be antibacterial, and their primary mode of action may include dissolving bacterial and fungal cell walls.
The antimicrobial activity of Adathoda beddomei was demonstrated against different pathogenic and non-pathogenic bacteria. Identification of endophytes was done based on external morphological characteristics with the help of a scanning electron microscope (SEM).
Natural compounds derived from endophyte bacteria with a very low molecular mass can be used to discover new and important structures for different pharmaceuticals and agrochemicals.
Current Bioactive CompoundsPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.90
自引率
0.00%
发文量
112
期刊介绍:
The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.